Surgery as local consolidation therapy before progression in oncogene-driven stage IV NSCLC: a patient and advocacy perspective | Synapse
March 26, 2026Open Access
Surgery as local consolidation therapy before progression in oncogene-driven stage IV NSCLC: a patient and advocacy perspective
Key Points
To discuss the perspectives of patients and advocates on the use of surgery for oncogene-driven stage IV NSCLC.
Gather insights from patient advocates and community founders.
Explore the role of surgery as a consolidation therapy before disease progression.
Highlight the importance of patient and advocacy perspectives in treatment decisions.
Demonstrate a need for incorporating patient feedback into surgical approaches for NSCLC.
Abstract
The authors of this editorial are patients, advocates and founders of communities representing people living with oncogene-driven non-small cell lung cancer (NSCLC).